Few reports have described in detail a true autoactivation process, where no extrinsic cleavage factors are required to initiate the autoactivation of a zymogen. Herein, we provide structural and mechanistic insight into the autoactivation of a multidomain serine protease: mannose-binding lectin-associated serine protease-2 (MASP-2), the first enzymatic component in the lectin pathway of complement activation. We characterized the proenzyme form of a MASP-2 catalytic fragment encompassing its C-terminal three domains and solved its crystal structure at 2.4 Å resolution. Surprisingly, zymogen MASP-2 is capable of cleaving its natural substrate C4, with an efficiency about 10% that of active MASP-2. Comparison of the zymogen and active structures of MASP-2 reveals that, in addition to the activation domain, other loops of the serine protease domain undergo significant conformational changes. This additional flexibility could play a key role in the transition of zymogen MASP-2 into a proteolytically active form. Based on the three-dimensional structures of proenzyme and active MASP-2 catalytic fragments, we present model for the active zymogen MASP-2 complex and propose a mechanism for the autoactivation process.
Extrinsic activating factor-initiated autoactivation of a zymogen is a classic textbook case. To date, however, few reports have described a true autoactivation process, where no extrinsic cleavage factors are required and the autoactivating capacity is an inherent property of the zymogen. A physiologically important example of true autoactivation is the initiation of the complement cascade activation.
The complement system is one of the proteolytic cascade systems found in the blood plasma of vertebrates. It provides the first line of immune defense against invading pathogens. The complement system is a sophisticated network of proteins (involving more than 30 components), which can be activated via three different routes: the classical, the lectin, and the alternative pathways (1) . Activation of the complement system culminates in the destruction and clearance of invading microorganisms and damaged or altered host cells. The central components of the system are multidomain serine proteases, which are present in zymogen forms and activate each other in a cascade-like manner (2) . In the case of the classical and lectin pathways, a recognition molecule binds to a specific target, and this provides the activation signal that is transmitted to serine protease zymogens, which in turn initiate the cascade (3) .
Mannose-binding lectin (MBL) 3 is the recognition subunit of the lectin pathway (4) . MBL binds to carbohydrate arrays (mainly to mannose and N-acetylglucosamine residues) on the surface of pathogens, which results in the autoactivation of MBL-associated serine protease-2 (MASP-2) (5, 6). Activated MASP-2 then cleaves C4 and C2, the precursors of the C3 convertase enzyme complex. MASP-2 is the only known MBL-associated protease that can directly initiate the complement cascade, playing a key enzymatic role in the lectin pathway.
The MBL-associated serine proteases together with C1r and C1s, the protease subcomponents of the first component of the classical pathway (C1), form a family of enzymes with identical domain organization (7) . The C-terminal trypsin-like serine protease (SP) domain is preceded by five noncatalytic modules. At the N terminus, there is a C1r/C1s/sea urchin Uegf/bone morphogenic protein (CUB) domain followed by an epidermal growth factor (EGF)-like module and a second CUB domain. This N-terminal CUB1-EGF-CUB2 region is responsible for the intersubunit interactions (e.g. interaction between the proteases and the recognition subunits). The following two complement control protein modules (CCPs), which associate directly with the SP domain, stabilize the structure of the SP domain and are involved in the proteolytic process.
In the case of C1s and MASP-2, which share almost the same substrate specificity, the CCPs were shown to provide accessory binding sites for the C4 substrate and thereby increase catalytic efficiency (8, 9) . The CCPs, however, do not increase the efficiency of C2 cleavage, indicating that the two substrates bind to different regions of the enzymes. MASP-1, MASP-2, and C1r are capable of autoactivation, where the zymogen proteases become cleaved and activated without the contribution of any extrinsic cleavage factor. The autoactivation is an inherent property of the serine protease domains, the other modules are not involved in this process (9, 10) . Our main priority was to characterize the structural background of the autoactivation process.
background of some important physiological properties of the MASP-2 enzyme. In this report, we characterize the zymogen catalytic fragment (CCP1-CCP2-SP) of MASP-2 and describe its x-ray structure. Based upon the zymogen and active structures, we present models for the autoactivating complex and propose a mechanism for autoactivation.
MATERIALS AND METHODS

Mutagenesis, Expression, and Purification of MASP-2 CCP1-CCP2-SP R444Q
Mutant-Mutagenesis was performed with the QuikChange site-directed mutagenesis kit (Stratagene, La Jolla, CA) according to the manufacturer's instructions. Recombinant plasmid for expression of wild type MASP-2 CCP1-CCP2-SP was used as template. Recombinant protein expression and renaturation were performed as described earlier (9) . The renatured protein solution was concentrated on ultrafiltration membrane (Millipore Corp., Bedford, MA), and it was carried through its isoelectric point (pI 5.6) by dropping it into a 0.5 M sodium acetate buffer (pH 5.0). The solution was dialyzed against 50 mM NaOAc, 0.5 mM EDTA (pH 5.0) and filtered on a 0.45-m nitrocellulose membrane. The renaturated protein was purified on a Mono S HR 5/5 column (Amersham Biosciences). It was eluted with a linear NaCl gradient from 200 to 600 mM. The collected fraction was once again carried through the isoelectric point by dropping it into a 1 M HEPES buffer (pH 7.4), and it was dialyzed against 20 mM HEPES, 145 mM NaCl, 5 mM EDTA (pH 7.4). The purification steps were monitored on SDS-PAGE.
Purification of C4-Human C4 was prepared from 20 ml of fresh serum according to the methods of Dodds (12) . The obtained protein was ϳ70% pure, and it was dialyzed against 20 mM HEPES, 145 mM NaCl, 0.5 mM EDTA (pH 7.4). Small C4 aliquots were frozen in liquid nitrogen and kept at Ϫ80°C. They were thawed only once and used up within 3 days.
Purification of Wild Type Zymogen MASP-2 CCP1-CCP2-SP-The expression, solubilization, renaturation, and dialysis were performed according to Ref. 9 . The protein was purified at the same conditions as it was in the case of the R444Q mutant except that the entire procedure was carried out at 4°C. Zymogen aliquots (1.93 M) were frozen in liquid nitrogen and kept at Ϫ20°C. Right before usage, zymogen aliquots, thawed and kept on ice and were consumed within 24 h.
Autoactivation of Wild Type Zymogen MASP-2 CCP1-CCP2-SPAutoactivation experiments were carried out under physiological conditions. The concentration of zymogen MASP-2 CCP1-CCP2-SP was 1.93 M. 12-14 samples were taken at various time points within 60 min from the beginning of incubation. An estimated half-life was given for the zymogen by measuring the diminution of the CCP1-CCP2-SP chain and the appearance of the SP domain on reducing SDS-PAGE. The quantification of these data was made by using a GEL DOC 1000 instrument and Molecular Analyst software for densitometric calculations (Bio-Rad). 2-4 parallel experiments were analyzed to determine the half-life of wild type zymogen.
Activation of MASP-2 CCP1-CCP2-SP R444Q Mutant-The R444Q (2.95 M) mutant was activated by thermolysin as described in Ref. 13 .
C4 Cleavage-To measure the kinetic parameters of the C4 cleavage by MASP-2 CCP1-CCP2-SP R444Q mutant and by the thermolysinactivated mutant, they were incubated with C4 at 37°C. Serial dilutions were made from mutant and substrate to find the optimal, well characterizable conditions. The concentration was 2.85 ϫ 10 Ϫ8 M, 6.11 ϫ 10
Ϫ9
M, and 6.08 ϫ 10 Ϫ7 M for the uncleaved R444Q mutant, the thermolysin-activated R444Q mutant, and the C4 substrate, respectively. Typically, 11-13 samples were taken within 55 min from the beginning of the reaction at various times. Data from 2-4 independent measurements were used for the calculations. The kinetic parameters were determined by visualizing and measuring the diminution of the ␣ chain of C4 on Coomassie-stained SDS-PAGE using a GEL DOC 1000 instrument and Molecular analyst software (Bio-Rad) for densitometric calculations. The reactions were assumed to be of the Michaelis-Menten type. The kinetic constants k cat , K m , and k cat /K m were estimated by unbiased, nonlinear regression methods, regressing the data on the following equation:
In the presence of C1 inhibitor, no cleavage could be detected, so this reaction was used as a negative control. The Effect of R444Q Mutant on the Autoactivation of Zymogen MASP-2 CCP1-CCP2-SP-Wild type zymogen MASP-2 CCP1-CCP2-SP (0.064 M) was incubated with a 10-fold excess of R444Q (0.64 M) mutant. Serial dilutions of the wild type zymogen were made to find a concentration at which the rate of autoactivation was slow enough. The incubations were carried out in 20 mM HEPES, 145 mM NaCl, 0.5 mM EDTA (pH 7.4) buffer at 37°C for 3 h. All of the samples were visualized on SDS-PAGE and were analyzed by densitometry as described above. The appearance of the SP domain was followed.
Cleavage of Synthetic Substrate-The cleavage rates of MASP-2 CCP1-CCP2-SP fragments on the synthetic substrate benzyloxycarbonyl-Gly-Arg-S-benzyl (MP Biomedicals Inc., Aurora, OH) were obtained as described in Ref. 11 .
Differential Scanning Calorimetry-Calorimetric measurements were performed on a VP-DSC (MicroCal) differential scanning calorimeter. Denaturation curves were recorded between 20 and 80°C at a pressure of 2,5 atm, using a scanning rate of 1°C/min. The protein concentration was set to 0.2 mg/ml. Samples were dialyzed against 20 mM Hepes (pH 7.4), 145 mM NaCl, and the dialysis buffer was used as a reference. Heat capacities were calculated as outlined by Privalov (14) .
Crystallographic studies on zymogen MASP-2 R444Q Mutant-Crystals of the zymogen MASP-2 CCP1-CCP2-SP R444Q mutant fragment were grown using the hanging drop method at 20°C. Crystals were obtained by mixing 2 l of reservoir solution and 2 l of protein solution. The reservoir solution contained 20% polyethylene glycol 6000, 0.2 M NaCl, 10% glycerol, and 0.1 M Tris-HCl, pH 8.0. The protein solution contained 1 mg/ml MASP-2 fragment in a buffer of 20 mM Tris/HCl, pH 7.4, and 0.03% NaN 3 .
Data were collected using the ID14 EH4 beam line at the European Synchrotron Radiation Facility at cryogenic temperatures. Data were processed with the XDS program package; they were scaled, merged, and reduced with XSCALE (15) .
The structure was solved by molecular replacement using the program MOLREP (16) of Collaborative Computing Project 4 (17) . The SP domain of the MASP-2 activated structure (11) (Protein Data Bank accession code 1Q3X) was used as a search model. Refinement was carried out with the REFMAC5 program (18), using restrained maximum likelihood refinement and TLS refinement (19) . ARP (20) was used for automatic solvent building. Model building was carried out using the O program (21) . The final model contains protein residues 296 -686 with the exception of residue 661. The stereochemistry of the structure was assessed with PROCHECK (22 ) segment of zymogen MASP-2 to the substrate binding site of the active structure. The AutoDock 3.05 (23) program has been used for docking the zymogen MASP-2 heptapeptide fragment to the active form. The charges were assigned to the structures by using SYBYL 6.5 (Tripos Associates Inc., St. Louis, MO). The initial conformation of the fragment was built and optimized by SYBYL 6.5. AutoDockTools was used to define the rotable bonds of the fragment. We used a Lamarckian genetic algorithm for the docking with local search, parameterized according to previous systematic optimization studies (24) (ga_run ϭ 200; generation ϭ 27.000; ga_num_evals ϭ 25.000.000; ga_pop_size ϭ 100, number of active torsion ϭ 18). In order to fit the zymogen MASP-2 to the docked fragment, we mutated back the structure in silico according to the wild type (Q444R (25) . A selection of energetically favorable loop conformations has been root mean square deviation-fitted to the docked heptapeptide. The Gly 442 -Tyr 446 peptide fragment of zymogen MASP-2 was replaced by the corresponding docked fragment. The obtained complex structure of zymogen and activated MASP-2 was energy-minimized, relaxed at 310 K by molecular dynamics simulation in water using GROMACS (26) . Coordinates of the MASP-2-MASP-2 complex model are available upon request.
RESULTS AND DISCUSSION
Characterization of the Recombinant Zymogen CCP1-CCP2-SP Fragment of MASP-2
Design of Stable Zymogen MASP-2 CCP1-CCP2-SP-The purpose of the present study was to investigate the autoactivation mechanism of the MASP-2 zymogen at various structural levels. MASP-2 possesses inherent autoactivating capacity and requires no extrinsic enzymatic factors for the autoactivation to occur. Wild type MASP-2, similarly to other trypsin-like proteases, can be activated through the cleavage of an Arg-Ile bond at the N-terminal region of the catalytic SP domain. We designed, constructed, and expressed an R444Q mutant of the catalytic fragment of MASP-2, thereby ensuring that the protein does not undergo autoactivation during the enzymatic characterization, crystallization, and structure determination processes. Gln was chosen on the basis of isomorphic replacement (27) and was predicted to have the least probability to interfere with the protein fold.
Stability of Zymogen MASP-2 CCP1-CCP2-SP R444Q Mutant-We expressed the R444Q mutant of the catalytic CCP1-CCP2-SP fragment of MASP-2 in E. coli cells. The wild type activated form of this fragment of MASP-2 has already been successfully expressed in the same expression system, and its biochemical properties have been characterized (9) . After renaturation, the R444Q mutant was purified to homogeneity by ion exchange chromatography. The purified protein migrated as a single band of 44 kDa on the reducing SDS-PAGE ( Fig. 1 ), indicating that no cleavage occurred within the polypeptide chain during expression and purification. In contrast to the R444Q mutant, the wild type fragment was fully activated after the same treatment. To assess the stability of the purified R444Q mutant, it was labeled with 125 I and was incubated with either buffer or human plasma at 37°C for 24 h. The samples were run on SDS-PAGE, and the proteins were visualized by autoradiography. No cleavage product could be observed (data not shown) demonstrating the stability of the R444Q zymogen even upon prolonged incubation at physiological conditions.
Folding of Zymogen MASP-2 CCP1-CCP2-SP R444Q
Mutant-To further characterize the folding and stability of our stable zymogen R444Q mutant, we measured the melting profile of the active wild type and the zymogen R444Q mutant by differential scanning calorimetry.
As the melting curves demonstrate (Fig. 2) , both fragments show a sharp, cooperative melting transition, indicating a compact, folded structure. The melting point of the active fragment (50.8°C) is 2.6°C higher than that of the zymogen form (48.2°C), and the calorimetric enthalpy change is also larger in the case of the active species. This difference can be explained by the stabilization effect of the activation process. During activation, the loosely bound, flexible loops of the activation domain become part of the more compact activated structure.
The zymogen mutant MASP-2 fragment showed no detectable activity on synthetic substrate (benzyloxycarbonyl-Gly-Arg-S-benzyl) even at very high levels of enzyme concentration (ϳ200 M), indicating that the catalytic machinery is disrupted in the zymogen and there is no active trypsin-like serine protease contamination in the purified material.
To confirm that the zymogen mutant MASP-2 CCP1-CCP2-SP fragment is correctly folded and can be converted into an active enzyme, it was treated with thermolysin (a non-trypsin-like) protease to specifically cleave the Gln 444 -Ile 445 bond (13) . The R444Q mutant was activated using limited proteolysis by thermolysin (Fig. 1) , giving rise to an active MASP-2 species with activity on a synthetic and a protein sub- strate comparable with that of the wild type MASP-2 fragment (TABLE  TWO) . The recovery of enzymatic activity of the R444Q mutant following thermolysin cleavage underlined that it is suitable for studying the structural and functional properties of zymogen MASP-2.
The Cleavage of C4 by Zymogen MASP-2 CCP1-CCP2-SP R444Q
Mutant-Previous studies demonstrated that a zymogen MASP-2 (S633A) mutant was able to form a complex with C4, a natural protein substrate of wild-type MASP-2 (29) . This is most probably due to the accessory C4 binding sites on the CCP2 module of MASP-2 (9). We incubated our stable zymogen R444Q MASP-2 with human C4 at 37°C. To our surprise, zymogen MASP-2 was able to cleave C4 with a high efficiency (Fig. 3, TABLE THREE ). This activity was completely abolished in the presence of C1 inhibitor, indicating that it was mediated by zymogen MASP-2 and not by other (potentially contaminating) protease. The fact that the K m values for the zymogen and the active enzyme are in the same range indicates that the accessory C4 binding site is present on both forms of the enzyme, and it is not affected by the conformation change of MASP-2 activation. Since zymogen MASP-2 showed no activity on synthetic substrate but was shown to cleave C4, we argue that the one-chain zymogen form of MASP-2 can adopt an active-like conformation, and this conformational change may be induced by the large protein substrate C4. Previously, it was shown that trypsinogen can be converted into an active state upon strong ligand binding (e.g. pancreatic trypsin inhibitor and Ile-Val dipeptide) without proteolytic cleavage (30) . A physiologically important example of a proteolytically active serine protease zymogen is tissue-type plasminogen activator, which has significant (10 -20%) activity relative to the twochain form (31) . The proteolytic activity of zymogen MASP-2 could be responsible for the first step of the autoactivation process, where a zymogen MASP-2 molecule cleaves and activates another zymogen MASP-2 molecule.
Autoactivation of MASP-2-The observed rate of MASP-2 autoactivation is concentration-dependent. At low concentrations (ϳ0.1 M) during renaturation, the catalytic fragment of wild type MASP-2 remains zymogen for several days. However, rapid autoactivation occurs during the subsequent concentration and purification steps (9) . To prepare wild type zymogen MASP-2, we adjusted the pH to 5.0 immediately after renaturation and performed the subsequent chromatographic steps at 4°C. At pH 5.0, the histidine residue in the catalytic triad becomes protonated, and the rate of the proteolysis decreases dramatically. Using this purification strategy, we managed to prepare wild type zymogen MASP-2, which remains relatively stable at pH 5.0 even at a relatively high concentration (3 M). At 4°C, it autoactivates slowly (its half-life is approximately 2 weeks), but at 37°C and pH 7.5, its half-life is only 26 min. The activation curve of the wild type zymogen MASP-2 shows the typical features of a true autoactivation process; it has a sigmoid shape with a lag phase at the beginning (Fig. 4) . In the lag phase of the autoactivation process the first reaction step dominates where zymogen molecules cleave zymogen molecules. It is a slow and concentration-dependent process. In the exponential phase of the activation curve, the second reaction step dominates where active MASP-2 molecules cleave zymogen MASP-2 molecules. The second step is much more efficient than the first one. We used the unactivated wild type enzyme and the R444Q mutant to prove unambiguously that in the first step of autoactivation a zymogen molecule cleaves another zymogen molecule. We used the wild type zymogen MASP-2 at a low concentration, where the rate of autoactivation is slow, and added a 10-fold molar excess of stable zymogen R444Q mutant (Fig. 5) . At low concentration (0.07 M), the autoactivation of wild type MASP-2 is very slow; after a 3-h incubation at 37°C, only 11% of the protease is activated. The presence of a 10-fold excess of the R444Q mutant, however, multiplies the rate of activation. After 3 h of incubation, 30% of the wild type MASP-2 is activated. This clearly shows that zymogen MASP-2 molecules excessively contribute to the enzymatic steps of the autoactivation process. Furthermore, since no extrinsic cleavage factors were detected in our preparations, it also indicates that a zymogen MASP-2 cleavage by another zymogen is the first step in the autoactivation of MASP-2. The facts that the autoactivation of the wild type MASP-2 fragment is strongly concentration-dependent and that a large excess of R444Q mutant is needed to detect the proteolytic activity of the zymogen MASP-2 against zymogen MASP-2 substrate suggest that, unlike C4, there is no accessory binding site on the zymogen CCP1-CCP2-SP fragment for the zymogen MASP-2 substrate. It should be noted, however, that the full-length MASP-2 molecules most probably exhibit higher rates of autoactivation as they dimerize through their CUB-EGF regions, and in the MBL-MASP-2 complex their catalytic domains are placed in a proper orientation to facilitate the autoactivation process (29, 32) .
Structural Studies
Crystal Structure of the CCP1-CCP2-SP Fragment of Zymogen R444Q
Mutant MASP-2-The structure of the zymogen mutant form of MASP-2 CCP1-CCP2-SP fragment was solved by molecular replacement and refined to 2.4 Å resolution (for electron density, see supplemental Fig. 1 ) (28) . All of the amino acid residues could be built in the electron density maps except for two regions. One of them is the first 12 residues of the sequence, including the Ala-Ser-Met extra tripeptide on the N terminus and residues Thr 287 -Ser 295 . The second one is residue 661 (c221) of the activation domain. (Throughout this work, MASP-2 numbering is used in comparisons with homologous proteins, together with chymotrypsin numbering (marked with "c") for the SP domain.) Some amino acid side chains are missing from the final model due to lack of electron density. These indicate flexible or destabilized regions in the molecule. Seven of them are grouped at the free end of the CCP1 module, probably due to lack of intermodule contacts with the CUB2 module. The remaining 14 missing side chains are located on the surface of the SP domain, most of them in the loops of the activation domain.
The overall structure is mace-like, showing the two CCP domains concatenated in a rodlike structure attached to the globular SP domain (Fig. 6A) .
Structure of the Complement Control Protein Modules of Zymogen R444Q Mutant MASP-2-
The fold of the CCP1 module with six ␤-strands is highly similar to that of C1r (33), except for two segments (root mean square distance for the backbone atoms: 0.92 Å). These are loop 350 -354 and region 306 -309. A striking feature of CCP1 module of MASP-2 is a large hydrophobic patch on the molecular surface formed by residues 299 -307 and 357-363. On the contrary, the spatial distribution of the polar and charged groups is more uniform to the corresponding domain of C1r. The possible role of this hydrophobic region in the function of MASP-2 is unknown.
The conformation of the CCP2 module is similar to that found in the wild type active MASP-2 structure (11) (Protein Data Bank accession code 1Q3X). The root mean square distances of backbone atoms are as follows: 0.47 and 0.77 Å for molecule A and B. This underlines the role of the CCP2 module in C4 binding. Our solution experiments revealed that zymogen and activated MASP-2 bind C4 with similar affinity. Since the structure of the SP domain undergoes major conformational changes during autoactivation, including the structure of the classical substrate binding region, it is very likely that the C4 binding site on the unchanged CCP2 module ensures the similar C4 binding affinity of the zymogen and the activated forms of MASP-2.
The region 360 -366 containing the linker between the two CCPs forms a ␤-strand. It forms backbone hydrogen bonds and further contacts with both CCPs, conserved across C1r and MASP-2. This is the reason why the relative orientations of the two CCPs are so similar in the MASP-2 and C1r structures. Although the amino acid sequence of the linker region shows only 50% similarity in MASP-2, C1r, and C1s, the segments contacting this linker (residues 330 -335, 414 -416, and 387-388 in MASP-2) show 67% similarity in the three enzymes, which is higher than the similarity of the whole CCP1-CCP2 region (57%). These results support a model of the CCP1-CCP2-SP with a quasirigid CCP1-CCP2 junction rather than one with a flexible CCP1-CCP2 junction. Therefore, we suggest that the CCP1-CCP2 junction has only a minor role in orienting the SP domains of these proteins in their functional complexes during the process of autoactivation and/or cleaving their substrates.
The relative orientation of the CCP2 and SP domains in the zymogen MASP-2 structure is somewhat different from those observed in the MASP-2 active structures. The topology of hydrogen bonds and other contacts of the CCP2 and SP domains is similar to that of the molecule B in the structure of the MASP-2 active form (11) . The CCP2-SP hinge region of MASP-2, C1r, and C1s shows higher variability than the CCP1-CCP2 junction (34) , suggesting that its role is to orient the SP domain prior to its enzymatic action.
Structure of the Zymogen R444Q Mutant SP Domain-The SP domain shows some typical features of zymogen structures of the chymotrypsin family (35) . Compared with the active SP domain of MASP-2, it shows more residues in the generously allowed region of the Ramachandran map, whereas the number of residues in the most allowed region is smaller. The activation domain involving the activation peptide and loops 1, 2, and D as defined by Huber and Bode (36) (see TABLE FOUR; labels as in Ref. 37 ) shows a high degree of flexibility relative to the other parts of the structure, indicated by weaker electron density and higher B-factors, especially in the case of the first three loops.
Further comparison of the structure of the zymogen SP domain with that of the active form of MASP-2 reveals that the core structure of the chymotrypsin fold with the two six-stranded ␤-barrel domains is virtually equivalent in the two forms (Fig. 6B) . The catalytic triad possesses their active conformation, but the oxyanion hole and the substrate specificity pocket are missing (Fig. 6C) . Major structural differences are observed in the loop conformations of the activation domain usual among proteins of the chymotrypsin family. We detected further significant conformational changes in the neighboring loop 3 as well as loops lining the substrate binding groove from the other side (loops A, B, and C) (Fig. 6B) . These loops include regions loosely associated with the remaining part of the enzyme. These observations indicate that the SP domain of zymogen MASP-2 has a very flexible structure. Loops A, B, C, and 3 are usually unchanged upon activation of the chymotrypsin-like enzymes, but they show major conformation changes or they are partially disordered in another autoactivating enzyme, C1r (34) . This extra flexibility must be a general phenomenon in the case of the zymogen serine proteases with autoactivation ability, where the one-chain form of the enzyme must transiently convert from an inactive to an active conformation. We propose that the loops of the activation domain together with loops A, B, C, and 3 form an "autoactivation domain." The high flexibility of this region and the coordinated conformational changes of the loops make possible the formation of the proteolytically active zymogen. TABLE FOUR shows the backbone segments with different conformations in the zymogen and active forms of the SP domain MASP-2. These differences reveal that upon activation, loops 3, A, B, and C move toward the activation domain, thereby making the structure more compact. In the activation domain, loop D moves toward loops 1 and 2, opening up the substrate binding groove on the leaving group side (Fig. 6B) . These large scale movements result in a structure stabilized by more interatomic contacts.
Detailed structural analysis shed light on some remarkable features of the zymogen structure (Fig. 6C) , which, we believe, are related to the characteristic enzymatic activity of the zymogen enzyme.
The activation peptide is detached from the enzyme surface, having no specific interactions. This feature was reported for other members of the chymotrypsin family. This segment is also one of the regions with elevated B-factors. The mutated side chain of Gln 444 (c15) is packed above a hydrophobic cluster of side chains (Ile 567 c135, Pro 591 c161, and Leu 621 c185). In the native enzyme, Arg 444 could not form favorable interactions with those, and it is probably surrounded by the solvent. Thus, the activation peptide contains an approximately 8-residue-long flexible segment ready to clamp to the substrate binding subsites of the active enzyme. Loop 1, which precedes the active site serine, possesses a unique conformation. All but one residue of the 622-632 (c185a-c194) segment undergo major backbone conformation changes upon activation. The zymogen enzyme lacks the oxyanion hole and the S1 pocket as detected in several zymogen structures. The side chain of Asp 632 (c194), which forms a salt bridge with the amino terminus of the cleaved activation peptide in the active enzyme, is hydrogen-bonded to the amide NH of residues 573 (c141) and 574 (c142) of loop D. The side chain of the specificity-determining Asp 627 (c189) turns out in the solvent similarly to that of zymogen C1r. It is disordered, since it has few contacts with the rest of the residues. Surprisingly, the S1 pocket is blocked by the basic side chain of Arg 630 (c192). A basic residue in this position in an enzyme with trypsin-like substrate specificity is unusual in the chymotrypsin family. Arg 630 (c192) in the zymogen structure inhibits the binding or adequate positioning of the P1 basic residue of the substrate. This repulsive force could be compensated for if the substrate has an extended binding surface on the enzyme. This can be the reason of the detected difference in the activities observed on large substrates (extended binding surface) and a small one (limited binding surface).
Loop 2 linked by a disulfide bridge to loop 1 shows only minor conformational changes. Its ends seem to be more stabilized in the zymogen structure than in the active structure via elongation of the two adjacent ␤-strands. The middle part of loop 2 of the zymogen enzyme lacks all of its hydrogen bond interactions with the rest of the protein due to slight changes in the main chain conformation of the ends and the great difference in the structure of loop 1. We suggest that loop 2 is floppy in the zymogen enzyme, since it can move without great conformational rearrangements facilitating the conformational transition of the zymogen enzyme to the catalytically effective form.
The fourth part of the activation domain, loop D, is stabilized by several contacts in a highly different conformation in the active and zymogen structure of MASP-2. Its conformation is somewhat similar to that of zymogen proteinase C (38) . The N-terminal part of it stabilizes the side chain of Asp 632 (c194) by hydrogen bonds formed with residues 573 (c141) and 574 (c142). A few other enzymes (C1r, chymotrypsin, zymogen E (39), and proteinase C) also establish at least one of these hydrogen bonds in their zymogen forms. Loop D of MASP-2, however, also shields Ser 633 (c195) NH by a hydrogen bond with Thr 576 (c144) OH. The conformation of the 573-576 (c141-c144) segment sterically prevents the flipping of residue Asp 632 , and consequently it inhibits the formation of the oxyanion hole.
The Model of the Enzyme-Substrate Complex of Activated and Zymogen MASP-2-In order to study the structural details of the mechanism of MASP-2 autoactivation, we docked the zymogen MASP-2 SP domain to the substrate binding region of the activated SP domain and relaxed the structure by short molecular dynamics simulation. This model (Fig.  7 , A-C) demonstrates the second step of the autoactivation process, when an activated MASP-2 cleaves a zymogen MASP-2 molecule. The resulting complex structure possesses an extended binding surface between active and zymogen MASP-2 burying 1517 and 1665 Å 2 of the surface areas of the zymogen and active structures, respectively. The intermolecular interactions include 19 hydrogen bonds and four salt bridges. The interface is built up by residues of loops 1 and the activation loop as well as regions 564 -567 (c132-c135), 587-591 (c157-c161), and 640 -645 (c202-c205) of the substrate (zymogen) structure as well as loops 1, 2, 3, A, B, C, and D of the active enzyme (supplemental TABLE ONE). The central S1-P1 salt bridge is surrounded by regions of the two molecules that form mostly hydrophobic interactions. On the edge of the binding region of both molecules, four isolated clusters of charged and polar residues form predominantly electrostatic interactions (labeled in Fig. 7C) .
Accommodation of the P1 arginine (Arg 444 , c15) of zymogen MASP-2 in the S1 pocket of the active serine protease is characteristic to the trypsin-like serine proteases. The extended P5-P2Ј segment of the activation loop of the zymogen molecule forms several contacts of the substrate binding groove of the active enzyme (Fig. 7A) . In addition to the canonical hydrogen bonds of the P1 and P3 residues (oxyanion hole and antiparallel ␤-sheet formation with the enzyme), the backbone of the P5 P1Ј and P2Ј residues is also hydrogen-bonded to the enzyme. The P2-P5 residues with their small side chains are bound to a flat hydrophobic region contacted predominantly by loop C (S5 and S4 sites), loop 3 (S4 and S3 sites) and loop 2 (S3 and S2 sites). At the leaving group side, Leu 445 (c16, P1Ј) and Tyr 446 (c17, P2Ј) form several hydrophobic contacts with His 483 (c57) and residues of loops 1 and D (supplemental TABLE ONE). The extension of the S5-S2Ј binding region contains mostly nonpolar side chains. Outside these hydrophobic regions, there are four major hydrophilic regions with intermolecular hydrogen bonds and intermolecular salt bridges and further complementary electrostatic interactions (Fig. 7C) . Proposed Autoactivation Mechanism-The zymogen MASP-2 molecule, exhibiting enzymatic activity in solution, should possess different conformation from that detected in the crystal structure. The zymogen structure must undergo conformational changes to be able to bind the activation peptide of the other molecule, especially the P1 arginine, and to form the oxyanion hole.
Our model of the activated and zymogen MASP-2 complex can also provide information on this initial step of autoactivation. Merely overlaying the activated molecule of the model with the zymogen SP domain reveals that the favorable intermolecular contacts of the active-zymogen complex would be only partially destroyed in a zymogen-zymogen complex with similar orientation of the two molecules; large continuous contact regions are practically unchanged, including the binding region of the N-terminal end of the activation loop, most of the largest hydrophilic binding patch and the fourth hydrophilic region (Fig. 7D ). These regions possibly play an important role in preorienting the two SP heads and forming an initial complex between them.
The remaining parts of the binding region undergo conformational changes during activation or during a conformational transition from the zymogen to the active-like state. Some of those make steric clashes and unfavorable contacts for the overlaid zymogen structure (Fig. 7D) . These regions of the binding surface might have a role in the zymogen to active-like conformational transition of MASP-2 in two possible ways; the conformational change may be driven by another MASP-2 molecule in a substrate position through an induced fit mechanism and/or by stabilizing the active-like conformation. One of the key points of the of the zymogen molecule (light blue carbon atoms) by the activated enzyme (magenta carbon atoms). The figure was prepared using a representative structure of the molecular dynamics simulation of the complex of SP domains. Oxygen and nitrogen atoms are colored red and blue, respectively, and hydrogen bonds are represented as shaded green lines. Chymotrypsin numbering was applied for labeling residues. B, the enzyme-substrate complex of activated MASP-2 (molecular surface colored magenta) and zymogen MASP-2 (molecular surface colored light blue) CCP1-CCP2-SP fragments. C, molecular surface of the enzyme-substrate complex of activated (left) and zymogen MASP-2 (right; should be rotated by 180°a round the vertical axis to form the complex). The surface is colored based on electrostatic potential (blue, positive; red, negative). Four regions at the edge of the binding region have polar character, and these are labeled. D, contact surfaces of the zymogenzymogen MASP-2 complex. The protein molecules in the role of the enzyme (left) and substrate (right) are oriented similarly to those in C. The lower part of the contact surface (green) forms favorable interactions for both zymogene SP domains. The upper part of the contact surface (orange) with several unfavorable contacts (some shown as red arrows) is formed by loops of the activation domain of the SP domain on the left. It is likely, therefore, that a main driving force in the inactive-active conformational change of zymogen MASP-2 is to avoid these unfavorable interactions (left). A was created using Pymol (41), B was created using VMD (42) , and C and D were created using Insight II version 2000L (Accelrys Software Inc.). Electrostatic potential was calculated by the Delphi module of Insight II.
zymogen to active-like transition is the S1/P1 interaction. In the zymogen-like conformation, the interaction between Arg 630 (c192) blocking the S1 pocket and the approaching P1 arginine of the substrate is clearly unfavorable. This electrostatic repulsion, however, may initiate a conformation change of loop 1 and the formation of the oxyanion hole and S1 pocket. There are two other regions of the zymogen enzyme that would make bad contacts with the substrate prior to the conformational transition: loop D (the side chains Arg 578 , Phe 580 , and Thr 576 ) and loop 3 (Pro 605 and Pro 606 ). Although there are some other parts of the MASP-2 surface changing, these three regions should undergo most drastic conformational shift to form favorable interactions with the substrate.
To sum up the above observations, we propose the following framework for the autoactivation process when a zymogen MASP-2 molecule cleaves and activates another zymogen MASP-2 molecule. The first event is recognition and preorientation of a zymogen MASP-2 molecule by another MASP-2 molecule (Fig. 8A) . During this process, extended contact regions are formed between the two SP domains that remain virtually identical during the autoactivation event. Subsequently, the zymogen to active-like conformational transition of the first molecule occurs, driven by forming more favorable interactions with the substrate. This transition is likely to be initiated in its activation domain, since this region develops more favorable contacts with the substrate in the active-like conformation. The zymogen cleaves the substrate, and in the last step it releases the activated substrate molecule.
We propose that the second step of the autoactivation process, where the activated MASP-2 molecule cleaves the zymogen one resembles the canonical way of substrate cleaving by serine proteases (Fig. 8B) . Comparison of activated and zymogen MASP-2 structures and our model of the enzyme-substrate complex formed by them revealed that both the enzyme and the substrate structures are practically preformed for forming the canonical Michaelis complex.
Conclusion
The availability of the crystal structure of both the zymogen and activated form of the catalytic region of MASP-2 enabled us to study the structural details of the autoactivation mechanism of this serine protease. Although the crystal structure of the zymogen shows an inactive species with disrupted oxyanion hole and substrate binding pocket, our solution studies provided clear evidence that the proenzyme form of MASP-2 can exhibit proteolytic activity on protein substrates. One prerequisite of the zymogen to active transition is the flexibility of the zymogen SP domain structure. This notion was supported by the significant conformational change of several loops (the activation domain and loops A, B, C, and 3) and was reinforced by DSC measurements. The structure of the CCP2 module, however, which associates directly with the SP domain and most probably contains accessory binding site(s) for the large C4 substrate, does not change during activation. This can explain the relatively high efficiency of zymogen MASP-2 cleaving C4. By the molecular modeling of the active MASP-2 and zymogen MASP-2 enzyme-substrate complex, we provided a detailed analysis of the interactions between the two molecules at the atomic level during the autoactivation process. The model describes a rather extended contact surface between the two molecules involving both hydrophobic and charged regions. The large contact surface could explain why zymogen MASP-2 can cleave protein substrates, whereas it is inactive on a small synthetic one. The zymogen MASP-2 protein substrate interaction can induce and/or stabilize the transiently active conformation of the onechain form.
